Type 1 Diabetes Trial, Recruiting (NCT07483879)

Type 1 Diabetes Trial, Recruiting NCT07483879 Sponsor: Aristotle University Of Thessaloniki Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07483879 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children between 2 and 16 years of age
Children who have recently been diagnosed with type 1 diabetes for the first time
Children who are being admitted to hospital for their initial diabetes assessment and treatment
Children may be included whether or not they had a serious complication called diabetic ketoacidosis at the time of diagnosis
A parent or legal guardian must provide written consent for the child to participate

For a separate comparison group in the trial:

Healthy children of a similar age who do not have diabetes

Who may not be able to join:

Children who have been diagnosed with any form of diabetes before
Children who have a known long-term kidney condition
Children who have a known heart or blood vessel condition
Children who have an active infection or inflammatory condition that is not related to their diabetes
Children who are taking medications that could affect results related to kidney or heart markers

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Athanasios Christoforidis, Aristotle University Of Thessaloniki

Phone: +30 6958796612

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07483879

Sponsor: Aristotle University Of Thessaloniki

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: +30 6958796612

More information: https://clinicaltrials.gov/study/NCT07483879

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children between 2 and 16 years of age
Children who have recently been diagnosed with type 1 diabetes for the first time
Children who are being admitted to hospital for their initial diabetes assessment and treatment
Children may be included whether or not they had a serious complication called diabetic ketoacidosis at the time of diagnosis
A parent or legal guardian must provide written consent for the child to participate

For a separate comparison group in the trial:

Healthy children of a similar age who do not have diabetes

Who may not be able to join:

Children who have been diagnosed with any form of diabetes before
Children who have a known long-term kidney condition
Children who have a known heart or blood vessel condition
Children who have an active infection or inflammatory condition that is not related to their diabetes
Children who are taking medications that could affect results related to kidney or heart markers

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Aristotle University Of Thessaloniki

Registry

ClinicalTrials.gov

Start date

13 June 2025

Est. completion

1 December 2029

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Neutrophil Gelatinase-Associated Lipocalin; Kidney Injury Molecule-1; High-Sensitivity Troponin; N-terminal pro-B-type Natriuretic Peptide; Interleukin-6; C-reactive Protein

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov